Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

US Patent 7744888 · Granted Jun 29, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Optoelectronic package structure and method of manufacturing the same2025
Respiratory function testing system and respiratory function testing method ther2024
Antibodies specific to alpha-enolase and uses thereof2020
Anti-human TIM-3 antibodies and methods of use thereof2020
In vitro pre-conditioned bone marrow-derived mesenchymal stem cells and uses the2020
In vitro pre-conditioned bone marrow-derived mesenchymal stem cells and uses the2019
Tetravalent anti-PSGL-1 antibodies and uses thereof2019
Methods of treating with anti-PSGL-1 antibodies2018
Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using t2018
Hydrophilic self-immolative linkers and conjugates thereof2018
Methods of treating GVHD and transplant rejection with anti-PSGL-1 antibodies2017
Humanized alpha-enolase specific antibodies and methods of uses in cancer therap2016